The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

By Whittum-Hudson J.A.   Rudy D.   Gerard H.   Vora G.   Davis E.   Haller P.K.   Prattis S.M.   Hudson A.P.   Saltzman W.M.   Stuart E.S.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4061-4071

Elsevier

Access to resources Recommend Favorite

Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge

By Pal S.   Luke C.J.   Barbour A.G.   Peterson E.M.   de la Maza L.M.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1455-1465

Elsevier

Access to resources Recommend Favorite

Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge

By Pal S.   Barnhart K.M.   Wei Q.   Abai A.M.   Peterson E.M.   de la Maza L.M.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 459-465

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection

By Hua S.   Parnell M.   Caldwell H.D.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1023-1032

Elsevier

Access to resources Recommend Favorite

DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice

By Donati M.   Sambri V.   Comanducci M.   Di Leo K.   Storni E.   Giacani L.   Ratti G.   Cevenini R.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1089-1093

Elsevier

Access to resources Recommend Favorite